000 | 01073 a2200289 4500 | ||
---|---|---|---|
005 | 20250516154534.0 | ||
264 | 0 | _c20140127 | |
008 | 201401s 0 0 ger d | ||
022 | _a1439-3522 | ||
024 | 7 |
_a10.1055/s-0033-1335247 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSpeck, V | |
245 | 0 | 0 |
_a[Migraine - established concepts and new developments]. _h[electronic resource] |
260 |
_bFortschritte der Neurologie-Psychiatrie _cJun 2013 |
||
300 |
_a308-23 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article; Review | ||
650 | 0 | 4 |
_aAnalgesics _xtherapeutic use |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
650 | 0 | 4 | _aBotulinum Toxins, Type A |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMigraine Disorders _xclassification |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 |
_aTryptamines _xtherapeutic use |
700 | 1 | _aMaihöfner, C | |
773 | 0 |
_tFortschritte der Neurologie-Psychiatrie _gvol. 81 _gno. 6 _gp. 308-23 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-0033-1335247 _zAvailable from publisher's website |
999 |
_c22844164 _d22844164 |